Brain metabolites analysis in patients with type 2 diabetes and cognitive impairement
- Authors: Matveeva M.V1, Samoilova Y.G1, Zhukova N.G1, Kudlai D.A2
-
Affiliations:
- Siberian State Medical University
- State Research Center «Institute of Immunology» of the Federal Medical-Biological Agency
- Issue: Vol 17, No 4 (2019)
- Pages: 22-27
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2918/article/view/113115
- DOI: https://doi.org/10.29296/24999490-2019-04-04
- ID: 113115
Cite item
Abstract
Full Text
About the authors
M. V Matveeva
Siberian State Medical University
Email: matveeva.mariia@yandex.ru
Moscow Road, 2, Tomsk, 634050, Russian Federation
Y. G Samoilova
Siberian State Medical University
Email: matveeva.mariia@yandex.ru
Moscow Road, 2, Tomsk, 634050, Russian Federation
N. G Zhukova
Siberian State Medical University
Email: matveeva.mariia@yandex.ru
Moscow Road, 2, Tomsk, 634050, Russian Federation
D. A Kudlai
State Research Center «Institute of Immunology» of the Federal Medical-Biological Agency
Email: matveeva.mariia@yandex.ru
Kashirskoye sh., 24, Moscow, 115522, Russian Federation
References
- Biessels G.J., Kappelle A.C., Bravenboer B. et al. Cerebral function in diabetes mellitus. Diabetologia. 1994; 37 (7): 6.
- Strachan M.W, Price J.F., Frier B.M. Diabetes, cognitive impairment, and dementia. BMJ. 2008; 336 (7634): 6.
- Mukesh G. Gohel, Evaluation of glycemic control in patients with type 2 diabetes mellitus with and without microvascular complications International. Journal of Pharma and Bio Sciences. 2013; 4 (4): 794-802.
- Ross B., Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec. 2001; 265 (2): 54-84.
- Самойлова Ю.Г, Ротканк М.А., Жукова Н.Г, Матвеева М.В., Толмачев И.В., Тонких О.С., Кудлай Д.А. Применение магнитно-резонансных методов исследования головного мозга у пациентов с сахарным диабетом 1-го типа и когнитивной дисфункцией. Неврологический журнал. 2018; 23 (2): 86-92.
- Самойлова Ю.Г., Ротканк М.А., Жукова Н.Г., Матвеева М.В., Толмачев И.В., Кудлай Д.А. Вариабельность гликемии у пациентов с сахарным диабетом 1-го типа: связь с когнитивной дисфункцией и данными магнитно-резонансных методов исследования. Проблемы Эндокринологии. 2018. 64 (5): 286-291.
- Williams S.R. In vivo proton spectroscopy: experimental aspects and potential. In: Rudin M, editor. NMR basic principles and progress. Berlin: Springer, 1992; 55-71.
- Sahin I., Alkan A., Keskin L. et al. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J. Diabetes Complications. 2008; 22 (4): 254-60.
- Kreis R., Ross B.D. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology. 1992; 184 (1): 123-30.
- Modi S., Bhattacharya M., Sekhri T et al. Assessment of the metabolic profile in Type 2 diabetes mellitus and hypothyroidism through proton MR spectroscopy.Magn Reson Imaging. 2008; 26 (3): 420-5.
- Иванов Р, Секарева Г, Кравцова О., Кудлай Д., Лукьянов С., Тихонова И., Демин А., Максумова Л., Никитина И., Обухов А., Зайцев Д., Степанов А., Носырева М., Самсонов М. Правила проведения исследований биоаналоговых лекарственных средств (биоаналогов). Фармакокинетика и фармакодинамика. 2014; 1: 21-36.
- Biessels G.J., Deary I.J., Ryan C.M. Cognition and diabetes: a lifespan perspective. Lancet Neurol. 2008; 7 (2): 184-90.
- Xiao-Ying Yuan. Mild cognitive impairment in type 2 diabetes mellitus and related risk factors: a review. Published Online: 2017-07-12. DOI: https://doi.org/10.1515/ revneuro-2017-0016»-2017-0016
- Rdzak G.M., Abdelghany O. Does insulin therapy for type 1 diabetes mellitus protect against Alzheimer's disease? Pharmacotherapy. 2014; 34 (12): 1317-23. doi: https://doi.org/10.1002/phar.1494. Epub 2014 Oct 3.
- Clodfelder-Miller B.J., Zmijewska A.A., Johnson G.V, Jope R.S. Tau is hyperphos-phorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency. Diabetes. 2006; 55 (12): 3320-5.
- Zhou Y, Zhao Y, Xie H. et al. Alteration in amyloid p42, phosphorylated tau protein, interleukin 6, and acetylcholine during diabetes-accelerated memory dysfunction in diabetic rats: correlation of amyloid p42 with changes in glucose metabolism. Behav Brain Funct. 2015; 11: 24. doi: https:// doi.org/10.1186/s12993-015-0069-5.
- Sinha S., Ekka M., Sharma U. et al. Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy. BMC Res. 2014; 7: 1-7. https://doi.org/10.1186/1756-0500-7-41.
- Sahin I., Alkan A., Keskin L. et al. Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J. Diabetes Complications. 2008; 22 (4): 254-60.
- Rae C.D. A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra. Neurochem Res. 2014; 39 (1): 1-36.
- Gujar S.K., Maheshwari S., Bjorkman-Burtscher I., Sundgren P.C. Magnetic resonance spectroscopy. J. Neuroophthalmol. 2005; 25 (3): 217-26.
- Ross B., Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec. 2001; 265 (2): 54-84.
- Wang Y, Xu X.Y, Feng C.H. et al. Patients with type 2 diabetes exhibit cognitive impairment with changes of metabolite concentration in the left hippocampus. Metab. Brain Dis. 2015; 30:м 1027-34. https://doi.org/10.1007/s11011-015-9670-4